These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34184307)

  • 21. State anxiety predicts cognitive performance in patients with Parkinson's disease.
    Ehgoetz Martens KA; Silveira CRA; Intzandt BN; Almeida QJ
    Neuropsychology; 2018 Nov; 32(8):950-957. PubMed ID: 30284873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computerized testing in Parkinson's disease: Performance deficits in relation to standard clinical measures.
    Flannery SL; Jowett T; Garvey A; Cutfield NJ; Machado L
    J Clin Exp Neuropsychol; 2018 Dec; 40(10):1062-1073. PubMed ID: 29978753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Everyday functioning of people with Parkinson's disease and impairments in executive function: a qualitative investigation.
    Kudlicka A; Hindle JV; Spencer LE; Clare L
    Disabil Rehabil; 2018 Oct; 40(20):2351-2363. PubMed ID: 28597694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Nombela C; Rowe JB; Winder-Rhodes SE; Hampshire A; Owen AM; Breen DP; Duncan GW; Khoo TK; Yarnall AJ; Firbank MJ; Chinnery PF; Robbins TW; O'Brien JT; Brooks DJ; Burn DJ; ; Barker RA
    Brain; 2014 Oct; 137(Pt 10):2743-58. PubMed ID: 25080285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
    Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
    Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson's disease.
    Jones JD; Burroughs M; Apodaca M; Bunch J
    Neuropsychology; 2020 Jan; 34(1):24-30. PubMed ID: 31219297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syntax, action verbs, action semantics, and object semantics in Parkinson's disease: Dissociability, progression, and executive influences.
    Bocanegra Y; García AM; Pineda D; Buriticá O; Villegas A; Lopera F; Gómez D; Gómez-Arias C; Cardona JF; Trujillo N; Ibáñez A
    Cortex; 2015 Aug; 69():237-54. PubMed ID: 26103601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson's Disease.
    Jozwiak N; Postuma RB; Montplaisir J; Latreille V; Panisset M; Chouinard S; Bourgouin PA; Gagnon JF
    Sleep; 2017 Aug; 40(8):. PubMed ID: 28645156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-Task Effects During a Motor-Cognitive Task in Parkinson's Disease: Patterns of Prioritization and the Influence of Cognitive Status.
    Johansson H; Ekman U; Rennie L; Peterson DS; Leavy B; Franzén E
    Neurorehabil Neural Repair; 2021 Apr; 35(4):356-366. PubMed ID: 33719728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
    Hurtado-Pomares M; Terol-Cantero MC; Sánchez-Pérez A; Leiva-Santana C; Peral-Gómez P; Valera-Gran D; Navarrete-Muñoz EM
    PLoS One; 2018; 13(11):e0207698. PubMed ID: 30452476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Symbol-Digit Modalities Test in Mild Cognitive Impairment: Evidence from Parkinson's Disease Patients.
    Pascoe M; Alamri Y; Dalrymple-Alford J; Anderson T; MacAskill M
    Eur Neurol; 2018; 79(3-4):206-210. PubMed ID: 29597229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A time-efficient screening tool for activities of daily living functions in Parkinson's disease dementia.
    Sulzer P; Liebig L; Csoti I; Graessel E; Wurster I; Berg D; Liepelt-Scarfone I
    J Clin Exp Neuropsychol; 2020 Oct; 42(8):867-879. PubMed ID: 33043797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
    Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
    Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Timmers M; Van Nueten L; Salvadore G; Zaunbrecher D; Roeben B; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    J Neuropsychol; 2020 Mar; 14(1):69-84. PubMed ID: 30320954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive decline and quality of life in incident Parkinson's disease: The role of attention.
    Lawson RA; Yarnall AJ; Duncan GW; Breen DP; Khoo TK; Williams-Gray CH; Barker RA; Collerton D; Taylor JP; Burn DJ;
    Parkinsonism Relat Disord; 2016 Jun; 27():47-53. PubMed ID: 27094482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening of executive functions in patients with Parkinson's disease using the new rapid test PAL-5].
    Scheffels JF; Engels JE; Kalbe E; Kessler J
    Fortschr Neurol Psychiatr; 2018 Apr; 86(4):219-225. PubMed ID: 29186725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocognitive correlates of numerical abilities in Parkinson's disease.
    Burgio F; Filippini N; Weis L; Danesin L; Ferrazzi G; Garon M; Biundo R; Facchini S; Antonini A; Benavides-Varela S; Semenza C; Arcara G
    Neurol Sci; 2022 Sep; 43(9):5313-5322. PubMed ID: 35739332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facial emotion recognition and its relationship to cognition and depressive symptoms in patients with Parkinson's disease.
    Pietschnig J; Schröder L; Ratheiser I; Kryspin-Exner I; Pflüger M; Moser D; Auff E; Pirker W; Pusswald G; Lehrner J
    Int Psychogeriatr; 2016 Jul; 28(7):1165-79. PubMed ID: 26987816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.